Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Breast 4Sarcoma 3Head & Neck 3Gastrointestinal 3Gynecologic 2Genitourinary 2Dermatologic 2CNS 1

Conditions

Melanoma 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Virus Diseases 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma 1Brain Neoplasms 1

Interventions

pembrolizumab 22Nivolumab 17Magnetic Resonance Spectroscopy 12Specimen Handling 10Cyclophosphamide 9Radiosurgery 7Drug Therapy 6Radiotherapy 5Paclitaxel 5Ipilimumab 5fludarabine 4Biopsy 4trametinib 3sargramostim 3Trastuzumab 3Taxes 3Pemetrexed 3Metformin 3Interleukin-2 3Immunoglobulin G 3Gemcitabine 3Carboplatin 3Bevacizumab 3tremelimumab 2temsirolimus 2poly ICLC 2pertuzumab 2osimertinib 2motexafin gadolinium 2epacadostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × Oncolytic Virotherapy × Dermatologic × Clear all
NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Recruiting
20 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT05180851 2022-02-01

YSCH-01

Shanghai Fengxian District Central Hospital

Phase EARLY_PHASE1 Unknown
28 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡